Search research articles
Contact Us
Filters
Showing results (791-800 of 875) with videos related to
Page
of 88
Sort By:
Epilepsia
|
September 18, 2020
Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [<sup>11</sup> C]UCB-J positron emission tomography study
Sjoerd J Finnema, Takuya Toyonaga, Kamil Detyniecki, et al.
Oncotarget
|
February 14, 2018
<i>Brucella</i> induces unfolded protein response and inflammatory response via GntR in alveolar macrophages
Dong Zhou, Fei-Jie Zhi, Mao-Zhen Qi, et al.
World Journal of Urology
|
July 17, 2025
Novel risk predictor of spontaneous rupture and hemorrhage of renal cell carcinoma based on clinical and radiographic characteristics
Bin Lin, Xiao-Dong Li, Meng-Xin Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2016
Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme
Laigao Chen, Nabeel Nabulsi, Mika Naganawa, et al.
Pathology, Research and Practice
|
August 28, 2020
Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis
Yu-Peng Wu, Zhi-Bin Ke, Fei Lin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
First-in-Human Assessment of <sup>11</sup>C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
Mika Naganawa, Nabeel Nabulsi, Shannan Henry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2013
Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging
Ming-Qiang Zheng, Nabeel Nabulsi, Su Jin Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 9, 2014
Evaluation of 11C-BU99008, a PET ligand for the imidazoline2 binding sites in rhesus brain
Christine A Parker, Nabeel Nabulsi, Daniel Holden, et al.
Frontiers in Medicine
|
December 8, 2025
Multimodal MRI-based radiomics model for predicting short-term efficacy in nasopharyngeal carcinoma
Fei-Yi Zhuang, Tian-Xiu Zheng, Yi Wang, et al.
Cell Death & Disease
|
March 23, 2021
Kinesin family member 18B regulates the proliferation and invasion of human prostate cancer cells
Yu-Peng Wu, Zhi-Bin Ke, Wen-Cai Zheng, et al.
Page
of 88
Search research articles
Search
Showing results (791-800 of 875) with videos related to
Sort By:
Page
of 88
Epilepsia
|
September 18, 2020
Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [<sup>11</sup> C]UCB-J positron emission tomography study
Sjoerd J Finnema, Takuya Toyonaga, Kamil Detyniecki, et al.
Oncotarget
|
February 14, 2018
<i>Brucella</i> induces unfolded protein response and inflammatory response via GntR in alveolar macrophages
Dong Zhou, Fei-Jie Zhi, Mao-Zhen Qi, et al.
World Journal of Urology
|
July 17, 2025
Novel risk predictor of spontaneous rupture and hemorrhage of renal cell carcinoma based on clinical and radiographic characteristics
Bin Lin, Xiao-Dong Li, Meng-Xin Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2016
Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme
Laigao Chen, Nabeel Nabulsi, Mika Naganawa, et al.
Pathology, Research and Practice
|
August 28, 2020
Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis
Yu-Peng Wu, Zhi-Bin Ke, Fei Lin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
First-in-Human Assessment of <sup>11</sup>C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
Mika Naganawa, Nabeel Nabulsi, Shannan Henry, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 29, 2013
Synthesis and evaluation of 11C-LY2795050 as a κ-opioid receptor antagonist radiotracer for PET imaging
Ming-Qiang Zheng, Nabeel Nabulsi, Su Jin Kim, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 9, 2014
Evaluation of 11C-BU99008, a PET ligand for the imidazoline2 binding sites in rhesus brain
Christine A Parker, Nabeel Nabulsi, Daniel Holden, et al.
Frontiers in Medicine
|
December 8, 2025
Multimodal MRI-based radiomics model for predicting short-term efficacy in nasopharyngeal carcinoma
Fei-Yi Zhuang, Tian-Xiu Zheng, Yi Wang, et al.
Cell Death & Disease
|
March 23, 2021
Kinesin family member 18B regulates the proliferation and invasion of human prostate cancer cells
Yu-Peng Wu, Zhi-Bin Ke, Wen-Cai Zheng, et al.
Page
of 88